SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 31, Issue 4, 2013, Pages 509-510

Reply to S. Pauwels et al

(4) Folkerd, Elizabeth J a Dixon, J Michael b A'Hern, Roger P a Dowsett, Mitch c

a INSTITUTE OF CANCER RESEARCH (United Kingdom)

b Breakthrough Research Unit (United Kingdom)

c ROYAL MARSDEN HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN; LETROZOLE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; NITRILE; TRIAZOLE DERIVATIVE;

BODY MASS; ESTROGEN BLOOD LEVEL; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LETTER; LIMIT OF DETECTION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BLOOD; BREAST TUMOR; FEMALE; NEOPLASM; NOTE;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BODY MASS INDEX; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; TRIAZOLES;

EID: 84874772639 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2012.47.0609 Document Type: Letter

Times cited : (1)

References (6)

1
- 84874782120
- Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitors
- Pauwels S, Lintermans A, Neven P, et al: Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitors. J Clin Oncol 31:509, 2013
- (2013) J Clin Oncol , vol.31 , pp. 509
- Pauwels, S.¹ Lintermans, A.² Neven, P.³

2
- 13444251237
- Deficits in plasma oestradiol measurement in studies and management of breast cancer
- DOI 10.1186/bcr960
- Dowsett M, Folkerd E: Deficits in plasma oestradiol measurement in studies and management of breast cancer. Breast Cancer Res 7: 1-4, 2005 (Pubitemid 40214529)
- (2005) Breast Cancer Research , vol.7 , Issue.1 , pp. 1-4
- Dowsett, M.¹ Folkerd, E.²

3
- 67650337804
- Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: The HOBOE trial
- Rossi E, Morabito A, Di Rella F, et al: Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: The HOBOE trial. J Clin Oncol 27: 3192-3197, 2009
- (2009) J Clin Oncol , vol.27 , pp. 3192-3197
- Rossi, E.¹ Morabito, A.² Di Rella, F.³

4
- 84865184360
- Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer
- Folkerd EJ, Dixon JM, Renshaw L, et al: Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. J Clin Oncol 30: 2977-2980, 2012
- (2012) J Clin Oncol , vol.30 , pp. 2977-2980
- Folkerd, E.J.¹ Dixon, J.M.² Renshaw, L.³

5
- 33749541916
- Comparison of methods to measure low serum estradiol levels in postmenopausal women
- DOI 10.1210/jc.2005-2378
- Lee JS, Ettinger B, Stanczyk FZ, et al: Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 91: 3791-3797, 2006 (Pubitemid 44536845)
- (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.10 , pp. 3791-3797
- Lee, J.S.¹ Ettinger, B.² Stanczyk, F.Z.³ Vittinghoff, E.⁴ Hanes, V.⁵ Cauley, J.A.⁶ Chandler, W.⁷ Settlage, J.⁸ Beattie, M.S.⁹ Folkerd, E.¹⁰ Dowsett, M.¹¹ Grady, D.¹² Cummings, S.R.¹³

6
- 43249113162
- Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer
- Dixon JM, Renshaw L, Young O, et al: Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. J Clin Oncol 26: 1671-1676, 2008
- (2008) J Clin Oncol , vol.26 , pp. 1671-1676
- Dixon, J.M.¹ Renshaw, L.² Young, O.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.